| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | A tetrahydroisoquinoline alkaloid obtained from a Caribbean tunicate Ecteinascidia turbinata. Used for the treatment of soft tissue sarcoma and relapsed ovarian cancer. (Chemical Entities of Biological Interest Ontology, CHEBI_84050) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=TRABECTEDIN |
| Similar Terms | |
| Downloads & Tools |
5 interacting proteins for the TRABECTEDIN drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| PARP1 | poly (ADP-ribose) polymerase 1 | 0.492391 |
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.415153 |
| FGFR2 | fibroblast growth factor receptor 2 | 0.203585 |
| ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | 0.101305 |
| TP53 | tumor protein p53 | 0.0460278 |